Anacalypsis Therapeutics

Health Sciences and Wellness

Anacalypsis Therapeutics is a company aiming at biotechnology innovation, focusing on developing medications and biomarkers for diseases of the central nervous system.

The team consists of neuroscientists with long experience in preclinical research and a passion for applying research-based knowledge to clinical practice.

Our primary goal is to develop and apply new treatments to address incurable neurological diseases and improve the patients’ quality of life. Specifically, we focus on studying early diagnostic tools (biomarkers) and new therapeutic approaches, aiming to reverse neurodegeneration and improve brain function.